Glibenclamide causing thrombocytopenia and bleeding tendency: case reports and a review of the literature
- PMID: 3129615
- DOI: 10.1007/BF01728201
Glibenclamide causing thrombocytopenia and bleeding tendency: case reports and a review of the literature
Abstract
We described two patients with severe thrombocytopenia and bleeding tendency related to treatment with glibenclamide (short-acting sulfonylurea). To the best of our knowledge, thrombocytopenic purpura associated with this medication has been reported only twice previously. We suggest that platelet count should be carried out early after initiating glibenclamide treatment and every 3 months thereafter.
Similar articles
-
[Thrombocytopenia due to glibenclamide].Harefuah. 1992 Apr 1;122(7):430, 479. Harefuah. 1992. PMID: 1592302 Hebrew.
-
[Acute thrombocytopenic purpura following glibenclamide medication].Med Welt. 1977 Jan 21;28(3):127-8. Med Welt. 1977. PMID: 402539 German. No abstract available.
-
Glibenclamide-induced cholestasis.J Hepatol. 1991 Nov;13(3):375. doi: 10.1016/0168-8278(91)90085-p. J Hepatol. 1991. PMID: 1808229 No abstract available.
-
The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.Braz J Med Biol Res. 1988;21(1):35-42. Braz J Med Biol Res. 1988. PMID: 3140992 Review.
-
Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.Expert Opin Investig Drugs. 2017 Jul;26(7):853-864. doi: 10.1080/13543784.2017.1333104. Epub 2017 Jun 1. Expert Opin Investig Drugs. 2017. PMID: 28541801 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical